Taking a red pen to NHS ambitions
This article was originally published in Clinica
It’s not all up for UK health secretary Andrew Lansley’s NHS reform plan, but the verdict to be delivered on it next month by NHS Future Forum chair Steve Field is set to force changes that will make it a pale shadow of the initiative the minister launched boldly last July.
You may also be interested in...
The December 12 UK general election returned a Conservative majority, the scale or which few would have predicted. It means that the new government can press on with its plans for Brexit, the uncertainty now surrounding only when, not if.
ConMed’s ambitions in orthopedics are to be the clinician’s support, develop differentiated offerings and avoid “me too” activity, before all notions of leading the market rankings.
In 2018, the top 100 publicly listed and reportable medical device technology companies had global sales spanning from over $30bn to some $100m in the lower reaches. As the latest In Vivo Medtech 100 ranking shows, many of the major changes in value sales were linked to company restructurings. But there were some impressive organic gains too.